Kun Hyung Kim1, Dae Hun Kim2, Hee Young Kim3, Gyung Mo Son4. 1. School of Korean Medicine, Pusan National University, Yangsan, South Korea. 2. Department of Acupuncture & Moxibustion, Korean Medicine Hospital, Pusan National University, Yangsan, South Korea. 3. Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital, Yangsan, South Korea. 4. Department of Surgery, Pusan National University Yangsan Hospital, Yangsan, South Korea.
Abstract
OBJECTIVE: To assess the efficacy/effectiveness and safety of acupuncture in patients recovering from colorectal cancer resection. METHODS: We systematically searched four English language databases (Medline, Embase, CENTRAL (Cochrane Central Register of Controlled Trials), and AMED (Allied and Complementary Medicine Database)) and one Chinese database (CAJ, China Academic Journals). Randomised trials of acupuncture compared with usual/routine care, sham interventions or active comparators in patients undergoing colorectal cancer resection were eligible for inclusion. Postoperative symptoms and quality of life (QoL) were the primary outcomes for the review. RESULTS: Of 1225 screened hits, seven randomised trials with 540 participants were included. High or uncertain risk of bias and significant heterogeneity were observed. All outcomes were measured before discharge, and no trial explicitly reported post-discharge outcomes. The response to acupuncture in terms of postoperative symptoms was inconsistent across trials. QoL was not measured in the included studies. For certain outcomes reflecting physiological recovery, favourable effects of acupuncture were observed compared with sham acupuncture, namely time to first flatus (n=207, three studies; mean difference (MD) -7.48 h, 95% CI -14.58 to -0.39 h, I(2)=0%) and time to first defaecation (n=149, two studies; MD -18.04 h, 95% CI -31.90 to -4.19 h, I(2)=0%). Two studies reported there were no acupuncture-related adverse events, whereas the remaining studies did not consider adverse events. CONCLUSIONS: We found low-to moderate-quality evidence for the efficacy and safety of acupuncture for recovery after surgery in colorectal cancer patients. Future trials with adequate allocation concealment, blinding of outcome assessors, and measurement of post-discharge outcomes including QoL or functional recovery are warranted. TRIAL REGISTRATION NUMBER: CRD42014015537. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
OBJECTIVE: To assess the efficacy/effectiveness and safety of acupuncture in patients recovering from colorectal cancer resection. METHODS: We systematically searched four English language databases (Medline, Embase, CENTRAL (Cochrane Central Register of Controlled Trials), and AMED (Allied and Complementary Medicine Database)) and one Chinese database (CAJ, China Academic Journals). Randomised trials of acupuncture compared with usual/routine care, sham interventions or active comparators in patients undergoing colorectal cancer resection were eligible for inclusion. Postoperative symptoms and quality of life (QoL) were the primary outcomes for the review. RESULTS: Of 1225 screened hits, seven randomised trials with 540 participants were included. High or uncertain risk of bias and significant heterogeneity were observed. All outcomes were measured before discharge, and no trial explicitly reported post-discharge outcomes. The response to acupuncture in terms of postoperative symptoms was inconsistent across trials. QoL was not measured in the included studies. For certain outcomes reflecting physiological recovery, favourable effects of acupuncture were observed compared with sham acupuncture, namely time to first flatus (n=207, three studies; mean difference (MD) -7.48 h, 95% CI -14.58 to -0.39 h, I(2)=0%) and time to first defaecation (n=149, two studies; MD -18.04 h, 95% CI -31.90 to -4.19 h, I(2)=0%). Two studies reported there were no acupuncture-related adverse events, whereas the remaining studies did not consider adverse events. CONCLUSIONS: We found low-to moderate-quality evidence for the efficacy and safety of acupuncture for recovery after surgery in colorectal cancerpatients. Future trials with adequate allocation concealment, blinding of outcome assessors, and measurement of post-discharge outcomes including QoL or functional recovery are warranted. TRIAL REGISTRATION NUMBER: CRD42014015537. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Kun Hyung Kim; Dae Hun Kim; Ji Min Bae; Gyung Mo Son; Kyung Hee Kim; Seung Pyo Hong; Gi Young Yang; Hee Young Kim Journal: BMJ Open Date: 2017-01-04 Impact factor: 2.692
Authors: Yihong Liu; Brian H May; Anthony Lin Zhang; Xinfeng Guo; Chuanjian Lu; Charlie Changli Xue; Haibo Zhang Journal: Evid Based Complement Alternat Med Date: 2018-07-29 Impact factor: 2.629
Authors: J Fleckenstein; P Baeumler; C Gurschler; T Weissenbacher; T Annecke; T Geisenberger; D Irnich Journal: Sci Rep Date: 2018-10-24 Impact factor: 4.379